Porvair (LON:PRV) Receives “Hold” Rating from Shore Capital Group

Shore Capital Group reissued their hold rating on shares of Porvair (LON:PRVFree Report) in a report issued on Monday morning, MarketBeat.com reports.

Porvair Trading Up 1.2%

Shares of PRV opened at GBX 860 on Monday. The company has a debt-to-equity ratio of 19.67, a current ratio of 1.83 and a quick ratio of 1.22. The firm has a 50 day simple moving average of GBX 841.98 and a 200-day simple moving average of GBX 781.31. Porvair has a 1-year low of GBX 624.70 and a 1-year high of GBX 920. The stock has a market cap of £396.77 million, a price-to-earnings ratio of 23.43 and a beta of 0.76.

Porvair (LON:PRVGet Free Report) last posted its earnings results on Monday, February 9th. The company reported GBX 42.30 earnings per share (EPS) for the quarter. Porvair had a return on equity of 10.75% and a net margin of 8.57%. Equities analysts forecast that Porvair will post 39.0358613 EPS for the current fiscal year.

Insider Activity at Porvair

In related news, insider Hooman Caman Javvi acquired 5,701 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average price of GBX 870 per share, for a total transaction of £49,598.70. 1.64% of the stock is currently owned by insiders.

About Porvair

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.

See Also

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.